Cargando…
Free Light Chains κ and λ as New Biomarkers of Selected Diseases
Diagnostic and prognostic markers are necessary to help in patient diagnosis and the prediction of future clinical events or disease progression. As promising biomarkers of selected diseases, the free light chains (FLCs) κ and λ were considered. Measurements of FLCs are currently used in routine dia...
Autores principales: | Gudowska-Sawczuk, Monika, Mroczko, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253807/ https://www.ncbi.nlm.nih.gov/pubmed/37298479 http://dx.doi.org/10.3390/ijms24119531 |
Ejemplares similares
-
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2019) -
Selected Biomarkers of Tick-Borne Encephalitis: A Review
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2021) -
The Clinical Significance of Serum Free Light Chains in Bladder Cancer
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2023) -
The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2022) -
Free Immunoglobulin Light Chains in Patients with Tick-Borne Encephalitis: Before and after Treatment
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2021)